NCT00640393 - Safety and Efficacy of Combining nbUVB to Etanercept in Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

February 28, 2010

Study Completion Date

March 31, 2010

Conditions

Psoriasis Vulgaris

Interventions

DRUG

Etanercept

Etanercept 50 mg, subcutaneous (SC) injection.

DEVICE

nbUVB

Trial Locations (10)

Winnipeg Clinic, Winnipeg

Sudbury Skin Clinic, Greater Sudbury

Mediprobe Research inc., London

The Guenther Dermatology Research Centre, London

Lynderm Research Inc., Markham

Bank on Beauty, Niagara Falls

Innovaderm Research Laval Inc, Laval

Clinique Dermatologique Fleury, Montreal

Innovaderm Research Inc., Montreal

Centre de Recherche Dermatologique du Quebec Metropolitain, Québec